| Words Of Wisdom Behavioral Health Services, Llc | |
|
240 Se 32nd Ave Homestead FL 33033-7153 | |
| (786) 222-3244 | |
| Not Available |
| Full Name | Words Of Wisdom Behavioral Health Services, Llc |
|---|---|
| Speciality | Behavior Analyst |
| Location | 240 Se 32nd Ave, Homestead, Florida |
| Authorized Official Name and Position | Nadege Saint Cyr (OWNER) |
| Authorized Official Contact | 7862223244 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Words Of Wisdom Behavioral Health Services, Llc 240 Se 32nd Ave Homestead FL 33033-7153 Ph: () - | Words Of Wisdom Behavioral Health Services, Llc 240 Se 32nd Ave Homestead FL 33033-7153 Ph: (786) 222-3244 |
| NPI Number | 1205500709 |
|---|---|
| Provider Enumeration Date | 08/06/2021 |
| Last Update Date | 08/06/2021 |
| Certification Date | 08/06/2021 |
| Medicare PECOS PAC ID | 3375917875 |
|---|---|
| Medicare Enrollment ID | O20230324000259 |
News Archive
Wanna make a fast buck? Quit smoking. According to the National Business Group on Health, which represents large employers including Wal-Mart and Wendy's, about 68% of its members either offer a discount of several hundred dollars on health insurance premiums to employees who quit smoking, or provide other incentives or penalties to make it happen (Borrell, 1/3).
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Last February, Fairview Southdale Hospital in Edina set out to try to reduce readmissions for Medicare patients as part of a pilot project with UCare, a small Minnesota health plan. The result: The 30-day readmission rate dropped by 44 percent. ... It's one way, experts say, that Medicare hopes to save billions of dollars (Lerner, 12/2).
Ibrutinib (IMBRUVICA) data presented yesterday by Pharmacyclics, Inc. at the American Association for Cancer Research Annual Meeting suggest that ibrutinib may be an effective therapeutic option for pancreatic ductal adenocarcinoma (PDAC), as shown in both a transgenic mouse model and an in-vivo model of patient-derived xenograft (PDX) mice (grafts of tissue taken from a pancreatic cancer patient and grafted into a mouse).
CSL Behring announced today that it has been granted Orphan Drug Designations by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia B patients with inhibitors.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205500709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
| Provider Name | Nadege Saint-cyr |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093252488 PECOS PAC ID: 9537422845 Enrollment ID: I20180420000292 |
News Archive
Wanna make a fast buck? Quit smoking. According to the National Business Group on Health, which represents large employers including Wal-Mart and Wendy's, about 68% of its members either offer a discount of several hundred dollars on health insurance premiums to employees who quit smoking, or provide other incentives or penalties to make it happen (Borrell, 1/3).
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Last February, Fairview Southdale Hospital in Edina set out to try to reduce readmissions for Medicare patients as part of a pilot project with UCare, a small Minnesota health plan. The result: The 30-day readmission rate dropped by 44 percent. ... It's one way, experts say, that Medicare hopes to save billions of dollars (Lerner, 12/2).
Ibrutinib (IMBRUVICA) data presented yesterday by Pharmacyclics, Inc. at the American Association for Cancer Research Annual Meeting suggest that ibrutinib may be an effective therapeutic option for pancreatic ductal adenocarcinoma (PDAC), as shown in both a transgenic mouse model and an in-vivo model of patient-derived xenograft (PDX) mice (grafts of tissue taken from a pancreatic cancer patient and grafted into a mouse).
CSL Behring announced today that it has been granted Orphan Drug Designations by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia B patients with inhibitors.
› Verified 8 days ago
News Archive
Wanna make a fast buck? Quit smoking. According to the National Business Group on Health, which represents large employers including Wal-Mart and Wendy's, about 68% of its members either offer a discount of several hundred dollars on health insurance premiums to employees who quit smoking, or provide other incentives or penalties to make it happen (Borrell, 1/3).
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Last February, Fairview Southdale Hospital in Edina set out to try to reduce readmissions for Medicare patients as part of a pilot project with UCare, a small Minnesota health plan. The result: The 30-day readmission rate dropped by 44 percent. ... It's one way, experts say, that Medicare hopes to save billions of dollars (Lerner, 12/2).
Ibrutinib (IMBRUVICA) data presented yesterday by Pharmacyclics, Inc. at the American Association for Cancer Research Annual Meeting suggest that ibrutinib may be an effective therapeutic option for pancreatic ductal adenocarcinoma (PDAC), as shown in both a transgenic mouse model and an in-vivo model of patient-derived xenograft (PDX) mice (grafts of tissue taken from a pancreatic cancer patient and grafted into a mouse).
CSL Behring announced today that it has been granted Orphan Drug Designations by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia B patients with inhibitors.
› Verified 8 days ago
Devonear Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 950 N Krome Ave Ste 405, Homestead, FL 33030 Phone: 305-246-0210 Fax: 305-246-0310 | |
Leap Home Care Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 25343 Sw 121st Ct, Homestead, FL 33032 Phone: 786-406-2937 | |
Bright Start Aba Services 2 Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15041 Sw 299th St, Homestead, FL 33033 Phone: 786-315-8971 | |
Ramirez Alejo Health Care Service Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1621 Nw 14th Ave, Homestead, FL 33030 Phone: 786-710-4665 | |
Homestead Aba Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 541 Se 34th Ter, Homestead, FL 33033 Phone: 305-397-3815 | |
Brown Consults Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 950 N Krome Ave Ste 405, Homestead, FL 33030 Phone: 305-246-0210 | |
Creative Community Mental Health Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 381 N Krome Ave Ste 206, Homestead, FL 33030 Phone: 786-601-9202 Fax: 786-668-6398 |